|
Bretylium Tosylate In Dextrose 5% In Plastic ContainerDrug - Bretylium Tosylate In Dextrose 5% In Plastic Container The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Bretylium Tosylate
Strength -
400MG/100ML
Applicant -
HOSPIRA
New Drug Application (NDA) Number -
019008
Product Number -
003
Therapeutic Equivalence (TE) Code -
AP
Approval Date -
Apr 29, 1986
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Hospira Inc
Bretylium Tosylate In Dextrose 5% In Plastic Container
Bretylium Tosylate In Dextrose 5% In Plastic Container 400mg/100ml Injectable; Injection
Bretylium Tosylate In Dextrose 5% 200mg/100ml Injectable; Injection Bretylium Tosylate In Dextrose 5% 400mg/100ml Injectable; Injection Bretylium Tosylate In Dextrose 5% 800mg/100ml Injectable; Injection Bretylium Tosylate In Dextrose 5% In Plastic Container 100mg/100ml Injectable; Injection Bretylium Tosylate In Dextrose 5% In Plastic Container 200mg/100ml Injectable; Injection Bretylium Tosylate In Dextrose 5% In Plastic Container 400mg/100ml Injectable; Injection Bretylium Tosylate In Dextrose 5% In Plastic Container 200mg/100ml Injectable; Injection Bretylium Tosylate In Dextrose 5% In Plastic Container 400mg/100ml Injectable; Injection Bretylium Tosylate In Dextrose 5% In Plastic Container 200mg/100ml Injectable; Injection NewDrugInformation |